학술논문
SER-109, an Investigational Microbiome Drug to Reduce Recurrence after Clostridioides difficile Infection: Lessons Learned from a Phase 2 Trial
Document Type
Article
Author
McGovern, B.H.; Ford, C.B.; Henn, M.R.; O'Brien, E.J.; Desjardins, C.A.; Bernardo, P.; Wortman, J.R.; Lombardo, M.-J.; Litcofsky, K.D.; Winkler, J.A.; McChalicher, C.W.J.; Li, S.S.; Tomlinson, A.D.; Nandakumar, M.; Cook, D.N.; Pomerantz, R.J.; Auninš, J.G.; Trucksis, M.; Pardi, D.S.; Khanna, S.; Hohmann, E.L.
Source
In: Clinical Infectious Diseases . (Clinical Infectious Diseases, 15 June 2021, 72(12):2132-2140)
Subject
Language
English
ISSN
15376591
10584838
10584838